HENRY SCHEIN INC HSIC
Nasdaq · XNAS · stock · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Chart by TradingView
4/9
Piotroski F — financial health
2.71
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $13.2B | $398.0M | $4.1B | — | $3.9B |
| 2024 | $12.7B | $390.0M | $4.0B | — | $4.0B |
| 2023 | $12.3B | $416.0M | $3.9B | — | $4.3B |
| 2022 | $12.6B | $538.0M | $3.8B | — | $4.1B |
| 2021 | $12.4B | $631.0M | $3.7B | — | $4.1B |
| 2020 | $10.1B | $404.0M | $2.8B | — | $4.0B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| DANIEL WILLIAM K | director | 2026-06-12 | Grant | 2,215 | — |
| BERGMAN STANLEY M | director | 2026-05-21 | Gift | 50 | — |
| BERGMAN STANLEY M | director | 2026-05-19 | Gift | 1,040 | — |
| DANIEL WILLIAM K | director | 2026-05-11 | Buy | 10,000 | $69.19 |
| Popeck Thomas C | CEO, Henry Schein Products | 2026-03-19 | Sell | 1,355 | $72.79 |
| Ettinger Michael S | EVP & Chief Operating Officer | 2026-03-17 | Gift | 1,000 | — |
| Sheehy Christine Zayac | SVP, Chief Human Res. Officer | 2026-03-16 | Tax withheld | 463 | $74.61 |
| Popeck Thomas C | CEO, Henry Schein Products | 2026-03-16 | Tax withheld | 587 | $74.61 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.71 (safe)
- Working capital / assets 0.11
- Retained earnings / assets 0.294
- EBIT / assets 0.058
- Equity / liabilities 0.607
Source: SEC EDGAR filings · CIK 0001000228 · as of 2025-12-27. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.